This psychedelics play has been selling off after announcing a private placement at .40. Just out of oversold area and close to completing a bullish MACD cross. My guess is that some of the financing participants are selling their .40 shares and keeping the free .50 warrant which creates an opportunity to get in at discount to financing. Management is highly...